Topic Hub
14 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 14 of 14 clinical reviews.
A clinical guide for adolescents aged 12 to 17 taking dutasteride (Avodart) and their families, covering what changes at 18, how to transfer prescriptions, ongoing monitoring requirements, and what the adult evidence base looks like.
Read clinical reviewA clinician-reviewed guide covering how dutasteride affects concentration, fatigue, sports eligibility, and academic performance in adolescents ages 12 to 17 prescribed Avodart for androgenetic alopecia or other off-label indications.
Read clinical reviewComplete caregiver guidance for administering dutasteride (Avodart) to patients aged 65 and older: dosing, safety precautions, handling rules, monitoring schedules, and when to call the prescriber.
Read clinical reviewA clinical review of how dutasteride (Avodart) affects men aged 65 and older, covering pharmacokinetics, BPH outcomes, prostate cancer risk, sexual side effects, cognitive concerns, and dosing guidance for geriatric patients.
Read clinical reviewA clinical review of dutasteride use in geriatric patients aged 65 and older, covering off-label indications, pharmacokinetics, drug interactions, and evidence from key trials.
Read clinical reviewA clinician-reviewed guide to how dutasteride (Avodart) affects cognitive function, driving, physical activity, and daily scheduling in adults aged 65 and older, with primary-source citations throughout.
Read clinical reviewA clinical review of dutasteride (Avodart) use in pediatric patients under age 12, covering hormonal developmental risks, FDA contraindications, 5-alpha reductase physiology in childhood, and what the evidence actually shows.
Read clinical reviewDutasteride (Avodart) is not approved for children under 12. This clinical guide covers the evidence base, safety concerns, off-label use contexts, and practical school and activity guidance for families navigating this situation.
Read clinical reviewA clinical guide to dutasteride use in pediatric patients under age 12 and what the transition to adult endocrinology or urology care looks like, including FDA status, trial evidence, dosing considerations, and monitoring protocols.
Read clinical reviewA clinician-reviewed guide to dutasteride use in men 65 and older, covering pharmacokinetics, BPH and prostate cancer risk reduction, safety monitoring, and how care transitions affect dosing and follow-up.
Read clinical reviewA clinical review of dutasteride (Avodart) off-label use in pediatric patients under age 12, covering pharmacology, safety data, reported uses, FDA status, and prescribing guidance for healthcare providers.
Read clinical reviewA clinical guide for caregivers administering dutasteride (Avodart) to adolescents aged 12 to 17, covering dosing, handling precautions, missed doses, storage, and when to call the prescriber.
Read clinical reviewA clinical deep-dive into dutasteride (Avodart) use in adolescents aged 12-17, covering hormonal development, DHT suppression risks, sexual maturation, bone health, fertility, and FDA prescribing guidance.
Read clinical reviewComplete caregiver guidance on dutasteride (Avodart) in children under 12: why it is contraindicated, teratogenic risks, accidental exposure protocols, and what FDA labeling actually says.
Read clinical review